SEC 13F Intelligence

Xponance LLC / PFE

Xponance LLC’s Pfizer Inc Position

Does Xponance LLC own Pfizer Inc (PFE)? Yes — 1.08M shares worth $30M (+0.22% of its 13F portfolio) as of Q1 2026, up from 952.3K shares the prior filed quarter.

Position Value
$30M
Q1 2026
Shares
1.08M
% of Portfolio
+0.22%
Quarters Held
24
currently held

Position History PFE

Reported value by quarter
Q2 ’20: $17MQ2 ’20Q3 ’20: $18MQ4 ’20: $18MQ1 ’21: $18MQ1 ’21Q2 ’21: $17MQ3 ’21: $18MQ4 ’21: $31MQ4 ’21Q1 ’22: $27MQ2 ’22: $27MQ3 ’22: $26MQ3 ’22Q4 ’22: $36MQ1 ’23: $30MQ2 ’23: $27MQ2 ’23Q3 ’23: $27MQ4 ’23: $26MQ1 ’24: $26MQ1 ’24Q2 ’24: $25MQ3 ’24: $24MQ4 ’24: $23MQ4 ’24Q1 ’25: $22MQ2 ’25: $22MQ3 ’25: $22MQ3 ’25Q4 ’25: $24MQ1 ’26: $30Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.08M$30M+0.22%
Q4 2025952.3K$24M+0.18%
Q3 2025874.6K$22M+0.18%
Q2 2025899.6K$22M+0.18%
Q1 2025854.9K$22M+0.21%
Q4 2024851.2K$23M+0.21%
Q3 2024816.9K$24M+0.23%
Q2 2024888.6K$25M+0.25%
Q1 2024938.8K$26M+0.27%
Q4 2023891.0K$26M+0.31%
Q3 2023799.2K$27M+0.36%
Q2 2023738.1K$27M+0.36%
Q1 2023737.8K$30M+0.44%
Q4 2022700.3K$36M+0.58%
Q3 2022598.2K$26M+0.50%
Q2 2022516.4K$27M+0.54%
Q1 2022528.2K$27M+0.45%
Q4 2021521.1K$31M+0.48%
Q3 2021415.9K$18M+0.34%
Q2 2021443.3K$17M+0.32%
Q1 2021486.3K$18M+0.37%
Q4 2020485.3K$18M+0.39%
Q3 2020479.6K$18M+0.43%
Q2 2020534.9K$17M+0.45%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Xponance LLC’s full portfolio or all institutional holders of PFE.